Jacobi Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-326
| Closed | -$60K | – | 1522 |
|
|
2021
Q2 | $60K | Sell |
326
-2,780
| -90% | -$512K | 0.01% | 589 |
|
|
2021
Q1 | $475K | Sell |
3,106
-100
| -3% | -$15.3K | 0.07% | 227 |
|
|
2020
Q4 | $501K | Sell |
3,206
-214
| -6% | -$33.4K | 0.08% | 200 |
|
|
2020
Q3 | $391K | Sell |
3,420
-74
| -2% | -$8.46K | 0.07% | 221 |
|
|
2020
Q2 | $392K | Buy |
3,494
+150
| +4% | +$16.8K | 0.07% | 204 |
|
|
2020
Q1 | $300K | Sell |
3,344
-413
| -11% | -$37.1K | 0.06% | 212 |
|
|
2019
Q4 | $406K | Sell |
3,757
-171
| -4% | -$18.5K | 0.07% | 208 |
|
|
2019
Q3 | $385K | Buy |
3,928
+3,850
| +4,936% | +$377K | 0.08% | 204 |
|
|
2019
Q2 | $10K | Hold |
78
| – | – | ﹤0.01% | 742 |
|
|
2019
Q1 | $11K | Hold |
78
| – | – | ﹤0.01% | 693 |
|
|
2018
Q4 | $8K | Hold |
78
| – | – | ﹤0.01% | 700 |
|
|
2018
Q3 | $11K | Hold |
78
| – | – | ﹤0.01% | 697 |
|
|
2018
Q2 | $10K | Hold |
78
| – | – | ﹤0.01% | 717 |
|
|
2018
Q1 | $8K | Hold |
78
| – | – | ﹤0.01% | 735 |
|
|
2017
Q4 | $9K | Hold |
78
| – | – | ﹤0.01% | 689 |
|
|
2017
Q3 | $11K | Sell |
78
-9
| -10% | -$1.27K | ﹤0.01% | 631 |
|
|
2017
Q2 | $11K | Hold |
87
| – | – | ﹤0.01% | 560 |
|
|
2017
Q1 | $10K | Buy |
87
+9
| +12% | +$1.03K | 0.01% | 470 |
|
|
2016
Q4 | $11K | Sell |
78
-9
| -10% | -$1.27K | 0.01% | 419 |
|
|
2016
Q3 | $11K | Buy |
87
+78
| +867% | +$9.86K | 0.01% | 466 |
|
|
2016
Q2 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 699 |
|